Display search results for ** instead (11 products)
15 Sep 2017  |  Global
This edition of the Future Tech TOE focuses on the emerging role of gamma delta T-cell platforms in immunotherapy applications. This service provides valuable insights across the global adoptive T-cell therapy landscape, while outlining the key unmet needs across this space. Apart from profiling key innovators in this space, the research encompasse...
11 Aug 2017  |  Global
This edition of Future Tech TechVision Opportunity Engine (TOE) covers the impact of wearable technology on the pharmaceutical industry. Wearables are wireless, sensor integrated devices worn on the body, which can accurately measure body physiological functions and alert users when abnormal parameter levels or fluctuations occur. All these attribu...
30 Aug 2016  |  Global
This Vital Signs issue discusses the clinical diagnostics laboratory tests payment system, approval of a Zika test kit, the impact on innovation of mergers in the pharma/biotech industry, and national healthcare expenditure projections through 2025.
USD 450.00 save 25 %
19 Aug 2016  |  Global
This Future Technology TOE depicts new healthcare trends across smart healthcare. The advent of personalized healthcare demands for improved connectivity for telemedicine, remote patient monitoring, electronic health records, and mobile health solutions. Development of applications for the internet of things (IoT) in the healthcare sector is the ke...
02 Aug 2016  |  Global
This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.
30 Jun 2016  |  Global
This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.
03 Jun 2016  |  Global
This edition of the Future Tech TOE highlights key trends and innovations across global hybrid neuroimaging technologies. While providing brief overviews of hybrid neuroimaging innovations, the TOE also covers drivers and challenges, market adoption scenarios, collaborations, and key patents across the global hybrid neuroimaging landscape. Furtherm...
24 May 2016  |  Global
This Vital Signs issues trends in orphan drugs, genetic research apps, Thermo Fisher Scientific's acquisition of Affymetrix, and the Zika Virus.
19 Feb 2016  |  Global
This edition of Future Tech TechVision Opportunity Engine (TOE) covers optical coherence tomography (OCT), a popular and fast-growing optical medical imaging technology. OCT is a non-ionizing and non-invasive imaging modality, giving it a functional edge over competing technologies. OCT also delivers micron-level resolution, real-time imaging and ...
12 Feb 2016  |  Global
Portfolio Expansions Follow Acquisitions by Panasonic Healthcare Holdings Co.,Thermo Fisher Scientific and Abbott Laboratories
This Vital Signs issues discusses Panasonic Healthcare's completed acquisition of Bayer's Diabetes Care Unit, Thermo Fisher Scientific's acquisition of Affymetrix, several moves in the single cell-genomics market by Bio-Rad, Illumina, Qiagen, and 10x Genomics, and Abbott's acquisition of Alere.